- Home
- TNGX vs ALX Comparison
TNGX vs ALX Comparison
Compare TNGX & ALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- ALX
- Stock Information
- Founded
- TNGX 2014
- ALX 1928
- Country
- TNGX United States
- ALX United States
- Employees
- TNGX N/A
- ALX N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- ALX Real Estate Investment Trusts
- Sector
- TNGX Health Care
- ALX Real Estate
- Exchange
- TNGX Nasdaq
- ALX Nasdaq
- Market Cap
- TNGX 1.0B
- ALX 1.2B
- IPO Year
- TNGX N/A
- ALX N/A
- Fundamental
- Price
- TNGX $7.99
- ALX $232.78
- Analyst Decision
- TNGX Strong Buy
- ALX
- Analyst Count
- TNGX 6
- ALX 0
- Target Price
- TNGX $10.80
- ALX N/A
- AVG Volume (30 Days)
- TNGX 4.3M
- ALX 75.8K
- Earning Date
- TNGX 11-04-2025
- ALX 11-03-2025
- Dividend Yield
- TNGX N/A
- ALX 7.77%
- EPS Growth
- TNGX N/A
- ALX N/A
- EPS
- TNGX N/A
- ALX 7.14
- Revenue
- TNGX $66,501,000.00
- ALX $215,838,000.00
- Revenue This Year
- TNGX $20.41
- ALX N/A
- Revenue Next Year
- TNGX N/A
- ALX N/A
- P/E Ratio
- TNGX N/A
- ALX $32.46
- Revenue Growth
- TNGX 53.29
- ALX N/A
- 52 Week Low
- TNGX $1.03
- ALX $184.76
- 52 Week High
- TNGX $9.70
- ALX $260.84
- Technical
- Relative Strength Index (RSI)
- TNGX 49.39
- ALX 51.56
- Support Level
- TNGX $7.12
- ALX $213.44
- Resistance Level
- TNGX $8.17
- ALX $240.00
- Average True Range (ATR)
- TNGX 0.74
- ALX 8.22
- MACD
- TNGX -0.07
- ALX 0.30
- Stochastic Oscillator
- TNGX 45.74
- ALX 72.40
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.